🔬

Seminar on Microbial Life and Resistance

Jan 29, 2025

Hybrid Seminar Notes: Understanding Microbial Life and Antibiotic Resistance

Introduction

  • Welcome to the seminar on the Cambridge Biomedical Campus Tours.
  • Technical details: Q&A at the end, online audience to submit questions.

Overview of LNB (MRC Laboratory of Molecular Biology)

  • Located on Addenbrooke's campus.
  • Focus on understanding biological processes at atomic, molecular, cellular, and organism levels.
  • Aims to address long-term biological problems impacting human health.

Speaker Introduction: Tanmay Bharat

  • Background:
    • BSc in Chemistry (University of Delhi, India)
    • BA in Biological Sciences (University of Oxford)
    • PhD from the European Molecular Biology Laboratory, Heidelberg (2012)
    • Postdoctoral training at LMBE with Jan Loewe
    • Group leader at University of Oxford, then returned to LMB as a program leader (2022)
  • Research focus: Understanding how bacteria evade antibiotic treatment and developing new treatment strategies.

Microbial Life

Overview of Microorganisms

  • Microorganisms include bacteria and archaea; humans are eukaryotes.
  • Bacterial cells lack compartmentalization, are simpler than eukaryotic cells.
  • Size comparison:
    • Human cells: ~100 microns
    • Prokaryotic cells: 1-10 microns
  • Microorganisms were the first life forms on Earth (5 billion years ago).

Distribution of Microorganisms

  • Estimated 1 trillion microbial species on Earth.
  • Microorganisms outnumber all plants and animals combined in terms of weight.
  • Found in various extreme environments:
    • Hot springs (Yellowstone)
    • Cold conditions (Antarctica)
    • Hyper-saline environments (Dead Sea)
    • Nuclear contaminated sites (Chernobyl)

Microbiome and Human Health

  • Humans host over 100 trillion microbes, beneficial for digestion and protection.
  • Imbalance can lead to diseases caused by bacteria such as:
    • Neisseria meningitis (meningitis)
    • Staph aureus (skin infections)
    • E. coli (urinary tract infections)

Antibiotic Treatments and Resistance

Discovery of Antibiotics

  • Penicillin discovered by Alexander Fleming; revolutionized treatment of bacterial infections.
  • Antibiotics target bacterial ribosomes without harming human cells.
  • Impact of antibiotics in history (e.g., during WWII).

Antibiotic Resistance

  • Bacteria develop resistance mechanisms, making treatment difficult.
  • Examples of resistant bacteria include:
    • Pseudomonas aeruginosa
    • Staph aureus
    • Shigella
  • Biofilm formation as a primary resistance mechanism:
    • Bacteria adhere to surfaces, forming protective extracellular matrices.
    • Over 75% of human infections involve biofilms.

Laboratory Research: Pseudomonas aeruginosa

Biofilm Structure and Function

  • Biofilms allow bacteria to survive antibiotic treatments.
  • Studying the organizational principles of biofilms in the lab to inform treatment approaches.

Research Findings

  • Identified a master adhesive protein that facilitates biofilm formation.
  • Created antibodies (nanobodies) that can penetrate biofilms and kill bacteria.
  • Investigating protective mechanisms of biofilm bacteria, including:
    • PF4 protein forming liquid crystalline droplets that shield bacteria from antibiotics.

Potential Treatments

  • Utilization of bacteriophages as an alternative therapy.
  • Development of new antibiotics derived from natural sources:
    • Darobactin and tyxobactin as promising new compounds.

Conclusion

  • Emphasis on collaboration between fundamental research and clinical application to combat antibiotic resistance.
  • Acknowledgment of past scientists’ contributions and current research efforts.
  • Closing remarks encouraged further inquiry into the microbiome and antibiotic resistance.